Biodegradable polymer drug-eluting stents: non-inferiority waiting for superiority?

Lancet. 2016 Nov 26;388(10060):2567-2568. doi: 10.1016/S0140-6736(16)32063-3. Epub 2016 Oct 30.

Authors

Aloke V Finn¹, Renu Virmani²

Affiliations

¹ CVPath Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA; University of Maryland School of Medicine, Baltimore, MD, USA.
² CVPath Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: rvirmani@cvpath.org.

PMID: 27806901
DOI: 10.1016/S0140-6736(16)32063-3

No abstract available

Publication types

Comment

MeSH terms

Absorbable Implants
Coronary Artery Disease / drug therapy
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention
Polymers
Sirolimus / therapeutic use*
Treatment Outcome

Substances

Polymers
Sirolimus